| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Low. Establishing a pathological diagnosis in degenerative dementias. Brain pathology (Zurich, Switzerland). vol 8. issue 2. 1998-06-12. PMID:9546296. |
diagnosis of pathologies causing the clinical syndrome of frontotemporal dementia can be ascertained using conventional staining supplemented by immunochemical detection of ubiquitin, tau protein and alpha beta crystallin. |
1998-06-12 |
2023-08-12 |
Not clear |
| J Takamatsu, A Kondo, K Ikegami, T Kimura, H Fujii, Y Mitsuyama, Y Hashizum. Selective expression of Ser 199/202 phosphorylated tau in a case of frontotemporal dementia. Dementia and geriatric cognitive disorders. vol 9. issue 2. 1998-05-05. PMID:9524799. |
selective expression of ser 199/202 phosphorylated tau in a case of frontotemporal dementia. |
1998-05-05 |
2023-08-12 |
Not clear |
| H Arai, Y Morikawa, M Higuchi, T Matsui, C M Clark, M Miura, N Machida, V M Lee, J Q Trojanowski, H Sasak. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochemical and biophysical research communications. vol 236. issue 2. 1997-08-28. PMID:9240421. |
cerebrospinal fluid tau (csf-tau) levels were quantified in 8 patients with frontotemporal dementia (ftd), 6 patients with progressive supranuclear palsy (psp), 3 patients with corticobasal degeneration (cbd), and 6 patients with dementia with lewy bodies (dlb). |
1997-08-28 |
2023-08-12 |
Not clear |
| M Jackson, J Low. The new neuropathology of degenerative frontotemporal dementias. Acta neuropathologica. vol 91. issue 2. 1996-09-26. PMID:8787144. |
the five main neurodegenerative disorders that underlie the clinical syndrome of frontotemporal dementia are distinguished using immunohistochemistry with antisera to ubiquitin and tau proteins. |
1996-09-26 |
2023-08-12 |
Not clear |
| P N Cooper, M Jackson, G Lennox, J Lowe, D M Man. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Archives of neurology. vol 52. issue 10. 1995-11-08. PMID:7575218. |
tau, ubiquitin, and alpha b-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. |
1995-11-08 |
2023-08-12 |
Not clear |
| P N Cooper, M Jackson, G Lennox, J Lowe, D M Man. Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia. Archives of neurology. vol 52. issue 10. 1995-11-08. PMID:7575218. |
we investigated the use of immunostaining with antibodies to tau, ubiquitin, and alpha b-crystallin in defining a protocol for the staged neuropathologic examination of brains from patients with a progressive frontotemporal dementia. |
1995-11-08 |
2023-08-12 |
Not clear |
| P Vermersch, R Bordet, F Ledoze, M M Ruchoux, F Chapon, P Thomas, A Destée, B Lechevallier, A Delacourt. [Demonstration of a specific profile of pathological Tau proteins in frontotemporal dementia cases]. Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie. vol 318. issue 4. 1995-09-28. PMID:7648357. |
[demonstration of a specific profile of pathological tau proteins in frontotemporal dementia cases]. |
1995-09-28 |
2023-08-12 |
human |